Literature DB >> 16403524

Amyloid-beta peptide disruption of lipid membranes and the effect of metal ions.

Tong-Lay Lau1, Ernesto E Ambroggio, Deborah J Tew, Roberto Cappai, Colin L Masters, Gerardo D Fidelio, Kevin J Barnham, Frances Separovic.   

Abstract

Beta-amyloid peptide (Abeta), which is cleaved from the larger trans-membrane amyloid precursor protein, is found deposited in the brain of patients suffering from Alzheimer's disease and is linked with neurotoxicity. We report the results of studies of Abeta1-42 and the effect of metal ions (Cu2+ and Zn2+) on model membranes using 31P and 2H solid-state NMR, fluorescence and Langmuir Blodgett monolayer methods. Both the peptide and metal ions interact with the phospholipid headgroups and the effects on the lipid bilayer and the peptide structure were different for membrane incorporated or associated peptides. Copper ions alone destabilise the lipid bilayer and induced formation of smaller vesicles but when Abeta1-42 was associated with the bilayer membrane copper did not have this effect. Circular dichroism spectroscopy indicated that Abeta1-42 adopted more beta-sheet structure when incorporated in a lipid bilayer in comparison to the associated peptide, which was largely unstructured. Incorporated peptides appear to disrupt the membrane more severely than associated peptides, which may have implications for the role of Abeta in disease states.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16403524     DOI: 10.1016/j.jmb.2005.11.091

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  43 in total

Review 1.  Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.

Authors:  Norman J Haughey; Veera V R Bandaru; Mihyun Bae; Mark P Mattson
Journal:  Biochim Biophys Acta       Date:  2010-05-07

2.  β-Barrel topology of Alzheimer's β-amyloid ion channels.

Authors:  Hyunbum Jang; Fernando Teran Arce; Srinivasan Ramachandran; Ricardo Capone; Ratnesh Lal; Ruth Nussinov
Journal:  J Mol Biol       Date:  2010-10-21       Impact factor: 5.469

Review 3.  Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications.

Authors:  Meaghan C Creed; Norton W Milgram
Journal:  Age (Dordr)       Date:  2010-04-20

Review 4.  How is protein aggregation in amyloidogenic diseases modulated by biological membranes?

Authors:  Christopher Aisenbrey; Tomasz Borowik; Roberth Byström; Marcus Bokvist; Fredrick Lindström; Hanna Misiak; Marc-Antoine Sani; Gerhard Gröbner
Journal:  Eur Biophys J       Date:  2007-11-21       Impact factor: 1.733

5.  Models of beta-amyloid ion channels in the membrane suggest that channel formation in the bilayer is a dynamic process.

Authors:  Hyunbum Jang; Jie Zheng; Ruth Nussinov
Journal:  Biophys J       Date:  2007-05-25       Impact factor: 4.033

6.  Exploring the mechanism of beta-amyloid toxicity attenuation by multivalent sialic acid polymers through the use of mathematical models.

Authors:  Christopher B Cowan; Dhara A Patel; Theresa A Good
Journal:  J Theor Biol       Date:  2009-02-13       Impact factor: 2.691

7.  Hen lysozyme amyloid fibrils induce aggregation of erythrocytes and lipid vesicles.

Authors:  Nitin Chaudhary; Ramakrishnan Nagaraj
Journal:  Mol Cell Biochem       Date:  2009-03-26       Impact factor: 3.396

Review 8.  Delineating the mechanism of Alzheimer's disease A beta peptide neurotoxicity.

Authors:  Roberto Cappai; Kevin J Barnham
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

9.  Amyloid β-peptide 1-42 modulates the proliferation of mouse neural stem cells: upregulation of fucosyltransferase IX and notch signaling.

Authors:  Yutaka Itokazu; Robert K Yu
Journal:  Mol Neurobiol       Date:  2014-01-17       Impact factor: 5.590

10.  Crystallization and preliminary X-ray diffraction analysis of the Fab fragment of WO2, an antibody specific for the Abeta peptides associated with Alzheimer's disease.

Authors:  Kwok S Wun; Luke A Miles; Gabriela A N Crespi; Kaye Wycherley; David B Ascher; Kevin J Barnham; Roberto Cappai; Konrad Beyreuther; Colin L Masters; Michael W Parker; William J McKinstry
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.